US Patent Issued to SINGAPORE HEALTH SERVICES on April 15 for "Method for classifying cancer patients into appropriate hepatocellular carcinoma treatment groups and compounds for treating the patient" (Singaporean Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,276,664, issued on April 15, was assigned to SINGAPORE HEALTH SERVICES PTE. LTD. (Singapore).

"Method for classifying cancer patients into appropriate hepatocellular carcinoma treatment groups and compounds for treating the patient" was invented by Suk Peng Chew (Singapore), Salvatore Albani (Singapore), Kah-Hoe Pierce Chow (Singapore) and Lu Pan (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for the prognosis of response to treatment for a patient suffering from cancer, the method comprising: measuring the expression of at least one immune marker in a leukocyte sample taken from the patient with cancer; classifying the patient sample...